CD177 and cancer: The results indicate that SPP1+ TAMs may interact with cancer cells in a paracrine pattern through expressing and secreting SPP1 then binding to cell-surface receptor CD44, consistent with a previous work, showing that CD44 is the receptor of SPP1 to regulate cancer metastasis (Wai and Kuo, 2004).